BU-NOT-SET

CONTACT US
The oncolytic efficacy and in vivo pharmacokinetics of [2-(4- Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) are governed by distinct stereochemical features
  • Drug substance
Eyes
Insight
Strategies to prepare for serialisation
  • Manufacturing
Eyes
Insight
A Versatile One-Pot Procedure for the Synthesis of 5-Aryl-6H- 1,3,4-thiadiazine-2-amines from Aromatic Ketones
  • Drug substance
Eyes
Insight
Fact sheet
  • Biologics
Plasmid DNA manufacturing capabilities
Insight
  • Analytical chemistry
  • Drug substance
Leveraging analytics throughout development and manufacture to achieve commercial success
Insight
  • Sustainability
2,300 solar panels installed at Recipharm’s Holmes Chapel
White paper
  • Analytical chemistry
  • Drug substance
Analysing prebiotic oligosaccharides for future product innovation
Insight
  • Industry trends
  • Manufacturing
Enhancing sterile processing for future vaccine programs
Insight
  • Sustainability
Increasing carbon emission transparency through SBTi contributions
Insight
  • Biologics
Single-use technologies are enabling increasing demand for biologics
Insight
  • Biologics
Overcoming the challenges surrounding manufacturing oncolytic viruses
Insight
  • Drug product
  • Industry trends
Insights from DCAT Week: Exploring drug storage, drug dosage and the supply chain